Detailed Drug Information for the Consumer

November 04, 2009

New Edition, New Title and Supplemental Updates

New Edition:




High-Acuity Nursing 5th Ed.

©2009 Pearson Education, Inc.

Authors/Editors: Kathleen Dorman Wagner RN, MSN, EdD (AED), Karen L. Johnson PhD, RN, CCRN and Melanie Hardin-Pierce, D.N.P., R.N., A.C.N.P., C.S.


The fifth edition of High Acuity Nursing delivers essential understanding of complex patients and instructs both students and nurses on how to provide nursing care in varied clinical settings. Broken down into a series of learner-focused modules, High Acuity Nursing takes complex information and presents it in smaller, more accessible chunks that promote easier mastery by readers. As the modules progress in difficulty, this text addresses the multiple-system problems that nurses face when caring for high acuity patients. With a focus on concepts and principles that can be applied across practice settings and patient populations, High Acuity Nursing, Fifth Edition is a learner friendly approach that will help nurses and nursing students master the concepts and confidence necessary to succeed in today’s health care settings.

New Title:





Clinical Periodontology and Implant Dentistry (2 Volumes)

5th Edition ©2008 Wiley-Blackwell (Munksgaard International Publishers)

Authors/Editors: J. Lindhe, N. P. Lang, T. Karring


The fifth edition of Clinical Periodontology and Implant Dentistry brings to its readers another iteration of the unrivalled, unparalleled work on the specialty of periodontics. The editors have brought together contributions from experts all over the world to provide the reader with a comprehensive, cohesive title that fuses scholarship and science with clinical instruction and pragmatism. Clinical Periodontology runs the gamut of sub-disciplines and topics within periodontics and implant dentistry, supporting an intellectually and internationally inclusive approach.

The fifth edition includes a wealth of new and revised chapters that reflect developments in the field in the years since the fourth edition was published. The sections on anatomy of the periodontium and the basic sciences underlying tooth and implant attachment have been expanded, as has the section on pathology and pathogenesis of periodontitis. Increased interest in the interdisciplinary aspects of periodontology is reflected by new chapters on orthodontic anchorage. Other important topics with increased prominence include: risk assessment and host-modulation therapies, regenerative therapies and a full discussion of surgical and non-surgical therapies.

With an approximate increase in length of 25% and over 15 new chapters, the 5th edition of Clinical Periodontology and Implant Dentistry has grown beyond the confines of one volume. Two volumes divide the topics into basic sciences and applied clinical concepts, at the same time maintaining a seamless integration between the two.

This title is the cornerstone of periodontology, and represents a unique distillation of the specialty by an expert group of authors under the tutelage of a legendary editorial team.

Supplemental Updates:





Medical Letter® On Drugs and Therapeutics, The

©2009-1995 The Medical Letter, Inc.

Authors/Editors: Mark Arbramwicz, MD et. al.



 

The Medical Letter on Drugs and Therapeutics is an independent, nonprofit publication that offers unbiased critical evaluations of drugs for physicians and other members of the health professions. This resource evaluates virtually all new drugs and also reviews older drugs when important new information becomes available on their usefulness or adverse effects. It is only available to single users online and covers the period from 1995-2008.*

What's New November 2, 2009 (Issue 1324)

Saxagliptin (Onglyza) for Type 2 Diabetes [51:1324]

Tadalafil (Adcirca) for Pulmonary Arterial Hypertension [51:1324]

In Brief: Injectable Paliperidone Palmitate for Schizophrenia

In Brief: A New Hib Booster What's New in October 2009:






DrugPoints® System ©2009 Thomson Healthcare, Inc.

Authors/Editors: Thomson Healthcare, Inc.

Rather than giving you too little or too much information, DrugPoints® System gives you direct access to the exact level of drug information you need to do your job. This evidence-based resource helps healthcare professionals prescribe, administer and monitor drugs safely and efficiently. Contains more than 1,400 concise, unbiased, synopses on drugs.

Features:

•Dosing & Indications

•Black Box Warnings

•Contraindications/Warnings

•Drug Interactions

•Adverse Effects

•Mechanism of Action/Pharmacokinetics

•Administration/Monitoring

•Toxicology

•Clinical Teaching

What's New in October 2009:

Azathioprine Sodium

Dextrose

Pralatrexate

Ustekinumab









 

Detailed Drug Information for the Consumer™ ©2009

Thomson Healthcare, Inc.

Authors/Editors: Thomson Healthcare, Inc.

Detailed Drug Information for the Consumer is a trusted resource for easy-to-understand, in-depth materials that provide education about medications.

Features:

•Clear, comprehensive information about medications and their proper use

•Advice written in lay language at a 12th-grade literacy level

•Easy-to-search indices and instant electronic access using keyword and hypertext links

•Greater detail than typical patient education leaflets, including: brand names, descriptions, proper use, precautions, side effects and instructions for how to handle missed doses

May 22, 2009

Detailed Drug Information for the Consumer™ - What's New in April 2009




Detailed Drug Information for the Consumer™

 ©2009 Thomson Healthcare, Inc.

Authors/Editors: Thomson Healthcare, Inc.


New Monographs:

AMOXICILLIN AND CLAVULANATE (Oral route)

AMPICILLIN AND SULBACTAM (Injection route)

ARTEMETHER AND LUMEFANTRINE (Oral route)

BENZOCAINE (Oral route, Oromucosal route)

BENZOCAINE (Topical application route)

DIBUCAINE (Topical application route)

DIVALPROEX SODIUM (Oral route)

EVEROLIMUS (Oral route)

HALOPERIDOL (Intramuscular route)

ISOSORBIDE DINITRATE (Oral route, Sublingual route)

ISOSORBIDE MONONITRATE (Oral route)

JAPANESE ENCEPHALITIS VIRUS VACCINE, INACTIVATED ADSORBED (Intramuscular route)

LIDOCAINE (Topical application route)

LIDOCAINE AND HYDROCORTISONE (Topical application route)

LIDOCAINE AND TETRACAINE (Topical application route)

NITROGLYCERIN (Intravenous route)

NITROGLYCERIN (Oral route, Sublingual route)

NITROGLYCERIN (Transdermal route)

PHENOL (Oromucosal route)

PHENYTOIN (Oral route)

PIPERACILLIN AND TAZOBACTAM (Intravenous route)

SCOPOLAMINE (Transdermal route)

TETRACAINE (Topical application route)

TICARCILLIN AND CLAVULANATE (Intravenous route)

VALPROIC ACID (Oral route)

Continue reading "Detailed Drug Information for the Consumer™ - What's New in April 2009" »

April 08, 2009

Detailed Drug Information for the Consumer: What's New in March 2009

Detailed Drug Information for the Consumer™
by Thomson Healthcare, Inc.
Thomson Healthcare, Inc., (2008)



NEW MONOGRAPHS:

  • BENZTROPINE (Injection route)
  • BENZTROPINE (Oral route)
  • BIPERIDEN (Oral route) 
  • DIGOXIN (Injection route)
  • DIGOXIN (Oral route) 
  • ETHOSUXIMIDE (Oral route)
  • ETHOTOIN (Oral route) 
  • FOSPHENYTOIN (Injection route) 
  • METHSUXIMIDE (Oral route)
  • PHENYTOIN (Injection route)
  • TEMOZOLOMIDE (Intravenous route)
  • TRIHEXYPHENIDYL (Oral route)
  • TRYPAN BLUE (Intraocular route)
  • VALPROATE SODIUM (Intravenous route)

Continue reading "Detailed Drug Information for the Consumer: What's New in March 2009" »

March 11, 2009

Detailed Drug Information for the Consumer: What's New in February, 2009

Detailed Drug Information for the Consumer™
by Thomson Healthcare, Inc.
Thomson Healthcare, Inc., (2008)





New Monographs:

  • 14C UREA (Oral route) 
  • ABACAVIR (Oral route)
  • ABACAVIR AND LAMIVUDINE (Oral route)
  • ABACAVIR, LAMIVUDINE, AND ZIDOVUDINE (Oral route)
  • ABARELIX (Intramuscular route, Injection route)
  • ABATACEPT (Intravenous route)
  • ABCIXIMAB (Intravenous route)
  • ACAMPROSATE (Oral route)
  • ACARBOSE (Oral route)
  • ACEBUTOLOL (Oral route)
  • ACETAMINOPHEN (Oral route, Rectal route)
  • ACETAMINOPHEN, SODIUM BICARBONATE, AND CITRIC ACID (Oral route)
  • ACETONE, ISOPROPYL ALCOHOL, AND POLYSORBATE (Topical route)
  • ACETYLCYSTEINE (Inhalation, oral/nebulization route)
  • ACITRETIN (Oral route)
  • ACYCLOVIR (Oral route, Intravenous route)
  • ACYCLOVIR (Topical route)
  • ADALIMUMAB (Subcutaneous route)
  • ADAPALENE (Topical route)
  • ADAPALENE AND BENZOYL PEROXIDE (Topical application route)

Continue reading "Detailed Drug Information for the Consumer: What's New in February, 2009" »

February 02, 2009

Detailed Drug Information for the Consumer: What's New in December, 2008

Detailed Drug Information for the Consumer™
by Thomson Healthcare, Inc.
Thomson Healthcare, Inc., (2008)



    New Monographs:

    • ELTROMBOPAG (Oral route)
    • EPINEPHRINE (Injection route)
    • PLERIXAFOR (Subcutaneous route)
    • SILODOSIN (Oral route)

    Revised Monographs:

    • 14C UREA (Oral route) 
    • ABACAVIR (Oral route)
    • ABACAVIR AND LAMIVUDINE (Oral route)
    • ABACAVIR, LAMIVUDINE, AND ZIDOVUDINE (Oral route)
    • ABARELIX
    • ABCIXIMAB (Intravenous route)
    • ACAMPROSATE (Oral route)
    • ACEBUTOLOL (Oral route)
    • ACETAMINOPHEN, SODIUM BICARBONATE, AND CITRIC ACID (Oral route)
    • ACETONE, ISOPROPYL ALCOHOL, AND POLYSORBATE (Topical route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in December, 2008" »

    December 08, 2008

    Detailed Drug Information for the Consumer: What's New in November 2008

    Detailed Drug Information for the Consumer™
    by Thomson Healthcare, Inc.
    Thomson Healthcare, Inc., (2008)



    New Monographs:

    • FESOTERODINE (Oral route)
    • LACOSAMIDE (Intravenous route) 
    • LACOSAMIDE (Oral route)
    • RUFINAMIDE (Oral route)

    Revised Monographs:

    • AMIFOSTINE (Intravenous route) 
    • AMLODIPINE AND ATORVASTATIN (Oral route) 
    • ANTICHOLINERGIC (Oral route, Parenteral route, Rectal route, Transdermal route) 
    • ANTICONVULSANT, DIONE (Oral route) 
    • ANTICONVULSANT, HYDANTOIN (Oral route, Parenteral route) 
    • ANTICONVULSANT, SUCCINIMIDE (Oral route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in November 2008" »

    November 05, 2008

    Detailed Drug Information for the Consumer: What's New in October, 2008

    Detailed Drug Information for the Consumer™
    by Thomson Healthcare, Inc.
    Thomson Healthcare, Inc., (2008)


    New Monographs:

    • ARGATROBAN (Intravenous route)
    • AZITHROMYCIN (Oral route)
    • C1 ESTERASE INHIBITOR, HUMAN (Intravenous route)
    • IOBENGUANE I 123 (Intravenous route)
    • LIDOCAINE (Ophthalmic route) 
    • ZIDOVUDINE (Intravenous route)

    Revised Monographs:

    • ALFUZOSIN (Oral route)
    • ALLOPURINOL (Intravenous route)
    • ALPRAZOLAM (Oral route)
    • AMLODIPINE AND BENAZEPRIL (Oral route)
    • AMLODIPINE AND VALSARTAN (Oral route)
    • ANTICONVULSANT, DIONE (Oral route)
    • ANTICONVULSANT, HYDANTOIN (Oral route, Parenteral route)
    • ANTICONVULSANT, SUCCINIMIDE (Oral route)
    • ANTIDEPRESSANT, MONOAMINE OXIDASE (MAO) INHIBITOR (Oral route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in October, 2008" »

    September 15, 2008

    Detailed Drug Information for the Consumer: What's New in August 2008

    Detailed Drug Information for the Consumer™
    by Thomson Healthcare, Inc.
    Thomson Healthcare, Inc., (2008)

    Detailed Drug Information for the Consumer is a trusted resource for easy-to-understand, in-depth materials that provide education about medications. Written at a 12th-grade literacy level, it features clear, comprehensive information, easy-to-search indices and instant electronic access using keyword and hypertext links.

    New Monographs

    • AMITRIPTYLINE (Oral route)
    • AMOXAPINE (Oral route)
    • CHLORPROPAMIDE (Oral route)
    • CLEVIDIPINE (Intravenous route)
    • CLONAZEPAM (Oral route)
    • DOXEPIN (Oral route)
    • GADOXETATE (Intravenous route)
    • GLIMEPIRIDE (Oral route)
    • GLIPIZIDE (Oral route)
    • GLYBURIDE (Oral route)
    • IMIPRAMINE (Oral route)
    • LEVOTHYROXINE (Injection route)
    • LEVOTHYROXINE (Oral route)
    • METHYL AMINOLEVULINATE (Topical application route)
    • NALTREXONE (Intramuscular route)
    • TEMAZEPAM (Oral route)
    • TOLAZAMIDE (Oral route)
    • TOLBUTAMIDE (Oral route)
    • TRIMIPRAMINE (Oral route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in August 2008" »

    August 11, 2008

    Detailed Drug Information for the Consumer: What's New in July 2008

    Detailed Drug Information for the Consumer
    by Thomson Healthcare, Inc.
    Thomson Healthcare, Inc., (2008)

    Detailed Drug Information for the Consumer is a trusted resource for easy-to-understand, in-depth materials that provide education about medications. Written at a 12th-grade literacy level, it features clear, comprehensive information, easy-to-search indices and instant electronic access using keyword and hypertext links.

    New Monographs

    • CLOMIPRAMINE (Oral route)
    • DIFLUPREDNATE (Ophthalmic route)
    • DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, POLIO VACCINE (Intramuscular route)
    • DIPHTHERIA, TETANUS, ACELLULAR PERTUSSIS, POLIO, HIB VACCINE (Intramuscular route)
    • NORTRIPTYLINE (Oral route)
    • PROTRIPTYLINE (Oral route)
    • REPAGLINIDE AND METFORMIN (Oral route)
    • ZIPRASIDONE (Intramuscular route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in July 2008" »

    June 12, 2008

    Detailed Drug Information for the Consumer: What's New in May 2008

    New Monographs

    • AMPHETAMINE AND DEXTROAMPHETAMINE (Oral route)
    • CERTOLIZUMAB PEGOL (Subcutaneous route)
    • CHLOROTHIAZIDE (Intravenous route)
    • CHLOROTHIAZIDE (Oral route)
    • CHLORTHALIDONE (Oral route)
    • DEXTROAMPHETAMINE (Oral route)
    • DILTIAZEM (Oral route)
    • HYDROCHLOROTHIAZIDE (Oral route)

    Continue reading "Detailed Drug Information for the Consumer: What's New in May 2008" »